More articles from Commentary

You have accessRestricted Access
Commentary on “Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in CKD”
Bryan R. Kestenbaum and Stephen L. Seliger

CJASN January 2019, 14 (1) 137-138; DOI: https://doi.org/10.2215/CJN.13431118

Add to Selected Citations
You have accessRestricted Access
Commentary on Complications of Immunosuppressive Treatments for Glomerulonephritis
Bryan R. Kestenbaum and Stephen L. Seliger

CJASN August 2018, 13 (8) 1276-1277; DOI: https://doi.org/10.2215/CJN.07610618

Add to Selected Citations
You have accessRestricted Access
Commentary on Treatment of Severe Hyponatremia
Stephen Seliger and Bryan Kestenbaum

CJASN April 2018, 13 (4) 650-651; DOI: https://doi.org/10.2215/CJN.13381217

Add to Selected Citations
You have accessRestricted Access
Commentary on Lessons from CKD–Related Genetic Association Studies—Moving Forward
Bryan Kestenbaum and Stephen L. Seliger

CJASN January 2018, 13 (1) 153-154; DOI: https://doi.org/10.2215/CJN.12421117

Add to Selected Citations
You have accessRestricted Access
Commentary on “Effectiveness of Treatment Modalities on Kidney Stone Recurrence”
Stephen L. Seliger and Bryan R. Kestenbaum

CJASN October 2017, 12 (10) 1709-1710; DOI: https://doi.org/10.2215/CJN.07780717

Add to Selected Citations
You have accessRestricted Access
Building an Ideal Quality Metric for ESRD Health Care Delivery
Jesse D. Schold, Laura D. Buccini, Michael P. Phelan, Colleen L. Jay, David A. Goldfarb, Emilio D. Poggio and John R. Sedor

CJASN August 2017, 12 (8) 1351-1356; DOI: https://doi.org/10.2215/CJN.01020117

Add to Selected Citations
You have accessRestricted Access
Commentary on Symptom Management of the Patient with CKD: The Role of Dialysis
Bryan Kestenbaum and Stephen L. Seliger

CJASN April 2017, 12 (4) 694-695; DOI: https://doi.org/10.2215/CJN.11781116

Add to Selected Citations
You have accessRestricted Access
The CKD Classification System in the Precision Medicine Era
Yoshio N. Hall and Jonathan Himmelfarb

CJASN February 2017, 12 (2) 346-348; DOI: https://doi.org/10.2215/CJN.09310916

Add to Selected Citations
You have accessRestricted Access
Commentary on Biomarkers for Early Detection and Prognosis of AKI
Bryan Kestenbaum and Stephen L. Seliger

CJASN January 2017, 12 (1) 174-175; DOI: https://doi.org/10.2215/CJN.07910716

Add to Selected Citations
You have accessRestricted Access
Commentary on Pharmacotherapy of Hypertension in Patients on Chronic Dialysis
Stephen L. Seliger and Bryan Kestenbaum

CJASN November 2016, 11 (11) 2076-2077; DOI: https://doi.org/10.2215/CJN.07740716

Add to Selected Citations

Main menu

User menu

Search

More articles from Commentary

Pages

About

Author Information

More information